Literature DB >> 9817924

Hereditary lymphedema: evidence for linkage and genetic heterogeneity.

R E Ferrell1, K L Levinson, J H Esman, M A Kimak, E C Lawrence, M M Barmada, D N Finegold.   

Abstract

Hereditary or primary lymphedema is a developmental disorder of the lymphatic system which leads to a disabling and disfiguring swelling of the extremities. Hereditary lymphedema generally shows an autosomal dominant pattern of inheritance with reduced penetrance, variable expression and variable age at onset. Three multigeneration families demonstrating the phenotype of hereditary lymphedema segregating as an autosomal dominant trait with incomplete penetrance were genotyped for 366 autosomal markers. Linkage analysis yielded a two-point LOD score of 6.1 at straight theta = 0. 0 for marker D5S1354 and a maximum multipoint LOD score of 8.8 at marker D5S1354 located at chromosome 5q34-q35. Linkage analysis in two additional families using markers from the linked region showed one family consistent for linkage to distal chromosome 5. In the second family, linkage to 5q was excluded for all markers in the region with LOD scores Z < -2.0. The vascular endothelial growth factor C receptor ( FLT4 ) was mapped to the linked region, and partial sequence analysis identified a G-->A transition at nucleotide position 3360 of the FLT4 cDNA, predicting a leucine for proline substitution at residue 1126 of the mature receptor in one nuclear family. This study localizes a gene for primary lymphedema to distal chromosome 5q, identifies a plausible candidate gene in the linked region, and provides evidence for a second, unlinked locus for primary lymphedema.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817924     DOI: 10.1093/hmg/7.13.2073

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  48 in total

1.  Cloning, expression and genomic structure of a novel human GNB2L1 gene, which encodes a receptor of activated protein kinase C (RACK).

Authors:  Shu Wang; Jin-Zhong Chen; Zhen Zhang; Shaohua Gu; Chaoneng Ji; Rong Tang; Kang Ying; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

2.  GJC2 missense mutations cause human lymphedema.

Authors:  Robert E Ferrell; Catherine J Baty; Mark A Kimak; Jenny M Karlsson; Elizabeth C Lawrence; Marlise Franke-Snyder; Stephen D Meriney; Eleanor Feingold; David N Finegold
Journal:  Am J Hum Genet       Date:  2010-05-27       Impact factor: 11.025

3.  Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax.

Authors:  John D Kanady; Michael T Dellinger; Stephanie J Munger; Marlys H Witte; Alexander M Simon
Journal:  Dev Biol       Date:  2011-04-16       Impact factor: 3.582

4.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

Review 5.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

6.  Lymphoedema-distichiasis and FOXC2: unreported mutations, de novo mutation estimate, families without coding mutations.

Authors:  Carolyn Sholto-Douglas-Vernon; Rachel Bell; Glen Brice; Sahar Mansour; Mansoor Sarfarazi; Anne H Child; Alberto Smith; Russell Mellor; Kevin Burnand; Peter Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

Review 7.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 8.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

9.  Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia.

Authors:  Fiona Connell; Kamini Kalidas; Pia Ostergaard; Glen Brice; Tessa Homfray; Lesley Roberts; David J Bunyan; Sally Mitton; Sahar Mansour; Peter Mortimer; Steve Jeffery
Journal:  Hum Genet       Date:  2009-11-13       Impact factor: 4.132

Review 10.  Molecular mechanisms of lymphangiogenesis.

Authors:  Meiko Takahashi; Takanobu Yoshimoto; Hajime Kubo
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.